Pneumococcal Titer Levels: Comparison Of Patients Receiving Intravenous Immunoglobulin Vs. Subcutaneous Immunoglobulin

被引：2
|
作者：
Abghari, Pamella [1 ,2 ]
Secord, Elizabeth A. [1 ,2 ]
Poowuttikul, Pavadee [1 ,3 ]
机构：
[1] Childrens Hosp Michigan, Dept Allergy Immunol, Detroit, MI 48201 USA
[2] Wayne State Univ, Detroit, MI USA
[3] Wayne State Univ, Sch Med, Pediat Allergy Immunol Div, Detroit, MI USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2014年 / 133卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2013.12.061
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
37
引用
收藏
页码：AB10 / AB10
页数：1
相关论文
共 50 条
  • [31] What Factors Influence Patients' Decisions To Stop Subcutaneous Immunoglobulin Therapy And Return To Intravenous Immunoglobulin Therapy?
    Graham, Emma
    Symons, Christine
    Trump, Teddie
    Leeman, Lucy
    Whyte, Andrew
    Bethune, Claire
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 13 - 14
  • [32] Intravenous and subcutaneous immunoglobulin G replacement therapy
    Bonilla, Francisco A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2016, 37 (06) : 426 - 431
  • [33] Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States
    Runken, Michael C.
    Noone, Joshua M.
    Blanchette, Christopher M.
    Zacherle, Emily
    Howden, Reuben
    AMERICAN HEALTH AND DRUG BENEFITS, 2019, 12 (06): : 294 - 303
  • [34] Subcutaneous immunoglobulin homo therapy gives higher trough levels than intravenous
    Björkander, JF
    Engl, W
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S189 - S189
  • [35] Indications and safety of intravenous and subcutaneous immunoglobulin therapy
    Rezaei, Nima
    Abolhassani, Hassan
    Aghamohammadi, Asghar
    Ochs, Hans D.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 301 - 316
  • [36] Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis
    Fu, Lisa W.
    Song, Christine
    Isaranuwatchai, Wanrudee
    Betschel, Stephen
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (02) : 195 - 199
  • [37] PROSPECTIVE ECONOMIC ANALYSIS OF HOME-BASED SUBCUTANEOUS IMMUNOGLOBULIN THERAPY VS HOSPITAL-BASED INTRAVENOUS IMMUNOGLOBULIN THERAPY
    Fu, L.
    Song, C.
    Betschel, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S96 - S96
  • [38] Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy
    Krishnarajah, Girishanthy
    Lehmann, Jee-Yeon K.
    Ellman, Brian
    Bhak, Rachel H.
    DerSarkissian, Maral
    Leader, Deane, Jr.
    Bullinger, Ann L.
    Duh, Mei Sheng
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (15): : S475 - S481
  • [39] Use of intravenous vs. subcutaneous darbepoetin in hemodialysis patients
    Gnanasekaran, I
    Barula, U
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A20 - A20
  • [40] RAPID TRANSITION OF PATIENTS ON INTRAVENOUS IMMUNOGLOBULIN REPLACEMENT TO SUBCUTANEOUS IMMUNOGLOBULIN REPLACEMENT IS FEASIBLE AND LEADS TO IMPROVED HEALTH ECONOMICS
    Fernando, Suran
    Weaver, Philippa
    Zaragoza, Reina
    Cvetanovski, Vera
    Li, Jamma
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 23 - 23
12345